Why the study?
Do implantable cardiac pacemakers improve symptoms in patients with medically refractory Stokes-Adams attacks?
Case Report (n=12)
Do implantable cardiac pacemakers improve symptoms in patients with medically refractory Stokes-Adams attacks?
Answers are grounded in this paper and cite their sources.
Implantable cardiac pacemakers can successfully relieve symptoms in patients with medically refractory Stokes-Adams attacks, though they carry risks of significant complications and mortality.
Implantable cardiac pacemakers have been inserted in 12 patients with Stokes-Adams attacks not controlled by medical therapy. The operation for insertion was well tolerated; however, three patients subsequently died, one of unrelated causes, and two of presumed arrhythmias. The nine survivors have all been greatly improved and are, in general, symptom free. Complications have included electrode failure in two patients, wound infection, diaphragmatic stimulation, and cerebrovascular accident. An electrode catheter placed in the right ventricle has been used successfully as an interim pacemaker in five of six patients. The presence of concurrent sinus and electrical pacemaking was well tolerated.
No takes yet. Share an insight, caveat, or question.
Brent M. Parker (1963) conducted a case report in Stokes-Adams attacks not controlled by medical therapy (n=12). Implantable cardiac pacemakers was evaluated on Survival and symptom improvement.
Synapse has enriched 10 related papers. Consider them for comparative context: